Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03372967 · ClinicalTrials.gov registry record
Project IMPACT Immunizations (IMProving America's Communities Together) Scaled Demonstration
A clinical trial of Influenza, sponsored by American Pharmacists Association Foundation.
- Completed
- Registry status
- 6,234
- Enrollment target
- 20
- Study locations
NCT03372967: Completed study of Influenza, sponsored by American Pharmacists Association Foundation.
NCT03372967 is a study of Influenza that has completed, run by American Pharmacists Association Foundation. The registered enrollment target is 6,234 participants, below the 36,764-participant average among 156 other Influenza trials with a reported enrollment target (83% lower). The trial reports 20 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03372967, a study of Influenza, has completed, sponsored by American Pharmacists Association Foundation.
- COMPLETED
- Registry status
- 6,234 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary objective of this study is to evaluate how implementing an innovative care model that provides the pharmacist access to a patient's vaccine history at the point-of-care impacts the pharmacist's ability to identify unmet vaccination needs and increase vaccination rates for routinely recommended adult vaccinations.
Primary Outcome
Change from baseline rates
Conditions Studied
Interventions
- BIOLOGICAL Vaccine administration by a pharmacist
- BEHAVIORAL Unmet vaccination needs identified and met
- BEHAVIORAL Vaccination forecast review and patient education
Study Locations (20)
Iowa
- Walmart Pharmacy - Atlantic
- Medicap Pharmacy - Carlisle
- NuCara Pharmacy - Coralville
- Eagle Pharmacy - Eagle Grove
- Medicap Pharmacy - Eldora
- Medicap Pharmacy - Indianola
- Towncrest Pharmacy - Iowa City
- Hy-Vee Pharmacy - Iowa City
- Walmart Pharmacy - Knoxville
- Osterhaus Pharmacy - Maquoketa
- Hy-Vee Pharmacy - Marion
- Walmart Pharmacy - Pella
- NuCara Pharmacy - Pleasant Hill
- NuCara Pharmacy - Traer
- Greenwood Pharmacy - Waterloo
- Meyer Pharmacy - Waverly
- Hy-Vee Pharmacy - West Des Moines
- NuCara Pharmacy - West Union
- Montross Pharmacy - Winterset
Washington
- Safeway Pharmacy - Bellevue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,234 participants |
| Start Date | 2017-12-12 |
| Est. Completion | 2019-11-20 |
What the finished NCT03372967 record still lists
NCT03372967 is an observational study that tracks outcomes without assigning an intervention. Its 6,234 participants enrollment target places it among the larger protocols in the corpus, below the 36,764-participant average among 156 other Influenza trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Influenza appearing as the primary indexed condition, and to 3 interventions - of which Vaccine administration by a pharmacist is the first listed.
NCT03372967 names 20 study sites across 2 states, led by Iowa, Washington.
Frequently Asked Questions
What is clinical trial NCT03372967 about?
NCT03372967 is a clinical study titled "Project IMPACT Immunizations (IMProving America's Communities Together) Scaled Demonstration". The primary objective of this study is to evaluate how implementing an innovative care model that provides the pharmacist access to a patient's vaccine history at the point-of-care impacts the pharmacist's ability to identify unmet vaccination needs and increase vaccination rates for routinely recom...
What is the current status of trial NCT03372967?
This trial is currently completed. The enrollment target is 6,234 participants. The study started on 2017-12-12. Estimated completion is 2019-11-20.
What conditions does trial NCT03372967 study?
This clinical trial studies the following conditions: Influenza.
What interventions are being tested in trial NCT03372967?
The interventions under investigation include: Vaccine administration by a pharmacist (BIOLOGICAL), Unmet vaccination needs identified and met (BEHAVIORAL), Vaccination forecast review and patient education (BEHAVIORAL).
Who is sponsoring clinical trial NCT03372967?
This trial is sponsored by American Pharmacists Association Foundation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03372967 being conducted?
This trial has 20 study locations across Iowa, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03372967's enrollment target sits among peer trials
6,234 15th of 156 higher than 142 of 156 other Influenza trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Influenza trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
pH1N1 Blinded Challenge Study
RECRUITING · Phase 1
-
B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults
RECRUITING · Phase 4
-
High vs. Standard Dose Influenza Vaccines in Lung Transplant (Repeater)
RECRUITING · Phase 2
-
Influenza Immunization in Adults Over Age 75
RECRUITING · NA
-
H5N1 Milk Detection Study
RECRUITING · NA
-
Screening for LID Clinical Studies Unit Healthy Volunteer Protocols
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03960099 · 6,250 participants · NA
Pictographs for Preventing Wrong-Patient Errors in NICUs
- NCT05440851 · 6,250 participants · NA
Platform of Randomized Adaptive Clinical Trials in Critical Illness
- NCT06566170 · 6,250 participants
A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease
- NCT04884802 · 6,254 participants · NA
The GUARDIAN Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI